Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 48

Cited In for PubMed (Select 12021343)


Anti-Hepatitis C Virus T-Cell Immunity in the Context of Multiple Exposures to the Virus.

Pfafferott K, Deshpande P, McKinnon E, Merani S, Lucas A, Heckerman D, Mallal S, John M, Gaudieri S, Lucas M.

PLoS One. 2015 Jun 24;10(6):e0130420. doi: 10.1371/journal.pone.0130420. eCollection 2015.


Influence of host resistance on viral adaptation: hepatitis C virus as a case study.

Plauzolles A, Lucas M, Gaudieri S.

Infect Drug Resist. 2015 Apr 7;8:63-74. doi: 10.2147/IDR.S49891. eCollection 2015. Review.


Inflammatory monocytes recruited to the liver within 24 hours after virus-induced inflammation resemble Kupffer cells but are functionally distinct.

Movita D, van de Garde MD, Biesta P, Kreefft K, Haagmans B, Zuniga E, Herschke F, De Jonghe S, Janssen HL, Gama L, Boonstra A, Vanwolleghem T.

J Virol. 2015 May;89(9):4809-17. doi: 10.1128/JVI.03733-14. Epub 2015 Feb 11.


T cell responses in hepatitis C virus infection: historical overview and goals for future research.

Holz L, Rehermann B.

Antiviral Res. 2015 Feb;114:96-105. doi: 10.1016/j.antiviral.2014.11.009. Epub 2014 Nov 26.


Protective immunity against hepatitis C: many shades of gray.

Abdel-Hakeem MS, Shoukry NH.

Front Immunol. 2014 Jun 16;5:274. doi: 10.3389/fimmu.2014.00274. eCollection 2014. Review.


Cross reactive cellular immune response to HCV genotype 1 and 4 antigens among genotype 4 exposed subjects.

Galal IF, Zakaria Z, Allam WR, Mahmoud MA, Ezzat AR, Osman A, Waked I, Strickland GT, Abdelwahab SF.

PLoS One. 2014 Jun 30;9(6):e101264. doi: 10.1371/journal.pone.0101264. eCollection 2014.


Detection and significance of cytotoxic cell subsets in biopsies of HCV-infected human livers.

Mozer-Lisewska I, Mania A, Kowala-Piaskowska A, Kluk A, Samara H, Pauli A, Żeromski J.

Arch Immunol Ther Exp (Warsz). 2014 Apr;62(2):153-60.


Immunity to viruses: learning from successful human vaccines.

Pulendran B, Oh JZ, Nakaya HI, Ravindran R, Kazmin DA.

Immunol Rev. 2013 Sep;255(1):243-55. doi: 10.1111/imr.12099. Review.


Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance.

Willimsky G, Schmidt K, Loddenkemper C, Gellermann J, Blankenstein T.

J Clin Invest. 2013 Mar;123(3):1032-43. doi: 10.1172/JCI64742. Epub 2013 Feb 1.


DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response.

Guo Z, Zhang H, Rao H, Jiang D, Cong X, Feng B, Wang J, Wei L, Chen H.

PLoS One. 2012;7(6):e38390. doi: 10.1371/journal.pone.0038390. Epub 2012 Jun 12. Erratum in: PLoS One. 2012;7(9). doi:10.1371/annotation/2ea71143-c033-43ff-8282-781b76c0a054.


Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection.

Abdelwahab SF, Zakaria Z, Sobhy M, Rewisha E, Mahmoud MA, Amer MA, Del Sorbo M, Capone S, Nicosia A, Folgori A, Hashem M, El-Kamary SS.

Clin Vaccine Immunol. 2012 May;19(5):780-6. doi: 10.1128/CVI.00050-12. Epub 2012 Mar 21.


The natural history of early hepatitis C virus evolution; lessons from a global outbreak in human immunodeficiency virus-1-infected individuals.

Thomson EC, Smith JA, Klenerman P.

J Gen Virol. 2011 Oct;92(Pt 10):2227-36. doi: 10.1099/vir.0.033910-0. Epub 2011 Jul 20. Review.


Immunodominance of HLA-A2-restricted hepatitis C virus-specific CD8+ T cell responses is linked to naive-precursor frequency.

Schmidt J, Neumann-Haefelin C, Altay T, Gostick E, Price DA, Lohmann V, Blum HE, Thimme R.

J Virol. 2011 May;85(10):5232-6. doi: 10.1128/JVI.00093-11. Epub 2011 Mar 2.


Strong hepatitis C virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children.

Hashem M, El-Karaksy H, Shata MT, Sobhy M, Helmy H, El-Naghi S, Galal G, Ali ZZ, Esmat G, Abdelwahab SF, Strickland GT, El-Kamary SS.

J Infect Dis. 2011 Mar 15;203(6):854-61. doi: 10.1093/infdis/jiq123. Epub 2011 Jan 21.


Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance.

Alter G, Jost S, Rihn S, Reyor LL, Nolan BE, Ghebremichael M, Bosch R, Altfeld M, Lauer GM.

J Hepatol. 2011 Aug;55(2):278-88. doi: 10.1016/j.jhep.2010.11.030. Epub 2010 Dec 17.


Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes.

Kim AY, Kuntzen T, Timm J, Nolan BE, Baca MA, Reyor LL, Berical AC, Feller AJ, Johnson KL, Schulze zur Wiesch J, Robbins GK, Chung RT, Walker BD, Carrington M, Allen TM, Lauer GM.

Gastroenterology. 2011 Feb;140(2):686-696.e1. doi: 10.1053/j.gastro.2010.09.042. Epub 2010 Sep 24.


Comparison of immune restoration in early versus late alpha interferon therapy against hepatitis C virus.

Abdel-Hakeem MS, Bédard N, Badr G, Ostrowski M, Sékaly RP, Bruneau J, Willems B, Heathcote EJ, Shoukry NH.

J Virol. 2010 Oct;84(19):10429-35. doi: 10.1128/JVI.01094-10. Epub 2010 Jul 28.


High throughput T epitope mapping and vaccine development.

Li Pira G, Ivaldi F, Moretti P, Manca F.

J Biomed Biotechnol. 2010;2010:325720. doi: 10.1155/2010/325720. Epub 2010 Jun 15. Review.


Conflicting selection pressures target the NS3 protein in hepatitis C virus genotypes 1a and 1b.

Irausquin SJ, Hughes AL.

Virus Res. 2010 Feb;147(2):202-7. doi: 10.1016/j.virusres.2009.11.001. Epub 2009 Nov 6.


HLA footprints on human immunodeficiency virus type 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering.

Matthews PC, Leslie AJ, Katzourakis A, Crawford H, Payne R, Prendergast A, Power K, Kelleher AD, Klenerman P, Carlson J, Heckerman D, Ndung'u T, Walker BD, Allen TM, Pybus OG, Goulder PJ.

J Virol. 2009 May;83(9):4605-15. doi: 10.1128/JVI.02017-08. Epub 2009 Feb 25. Erratum in: J Virol. 2011 May;85(9):4635.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk